ABIVAX Société Anonyme ABVX
89.60 USD +0.89 (+1.00%)
Nov 4, 2026, 11:48 AM EST
87.79 Day range 90.87
69.81 52-week range 148.83
- YTD
- -33.56%
- 1 year
- -9.16%
News
globenewswire.com Abivax to Participate in Upcoming Fall Investor Conferences Abivax to Participate in Upcoming Fall Investor Conferences PARIS, France – November 2, 2026 – 10:05 PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Wedbush Maintains Neutral on Abivax, Lowers Price Target to $96 Wedbush analyst David Nierengarten maintains Abivax (NASDAQ:ABVX) with a Neutral and lowers the price target from $118 to $96.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
seekingalpha.com Cedar Grove Capital Q3 2026 Portfolio Update During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and Suja Life Inc. During the quarter, we closed short positions in Bending Spoons SpA, Chipotle Mexican…
benzinga.com Abivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026Four oral presentations and three posters build upon Phase 3 ABTECT Maintenance and Induction programs in…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
seekingalpha.com Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts Abivax Société Anonyme is advancing obefazimod for ulcerative colitis and Crohn's, with recent safety concerns now largely addressed. ABVX raised $920 million, extending its cash runway into Q4 2029…
benzinga.com These Analysts Slash Their Forecasts On Abivax Following H1 Results Abivax SA (NASDAQ:ABVX) reported mixed results for the first half of the year on Monday.
benzinga.com These Analysts Slash Their Forecasts On Abivax Following H1 Results Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.
benzinga.com Truist Securities Maintains Buy on Abivax, Lowers Price Target to $151 Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and lowers the price target from $155 to $151.
benzinga.com Wedbush Maintains Neutral on Abivax, Lowers Price Target to $118 Wedbush analyst David Nierengarten maintains Abivax (NASDAQ:ABVX) with a Neutral and lowers the price target from $140 to $118.
benzinga.com Abivax H1 EPS $(2.43) Misses $(1.08) Estimate, Sales $2.959M Beat $1.860M Estimate Abivax (NASDAQ:ABVX) reported quarterly losses of $(2.43) per share which missed the analyst consensus estimate of $(1.08) by 125 percent. This is a 65.31 percent decrease over losses of $(1.47) per…
globenewswire.com Abivax Presents Business Updates and First Half 2026 Financial Results Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief Technical Officer to advance…
benzinga.com Earnings Scheduled For September 21, 2026 Companies Reporting Before The Bell • Ennis (NYSE:EBF) is expected to report earnings for its second quarter. Companies Reporting After The Bell • Abivax (NASDAQ:ABVX) is projected to report…
benzinga.com Nasdaq Gains Over 100 Points, Posts Weekly Gain: Investor Sentiment Improves Slightly, But Greed Index Remains in ‘Fear’ Zone Market sentiment improved slightly but stayed in Fear; stocks were mixed, the Dow had its worst week since March.
defenseworld.net Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Rating of “Moderate Buy” by Brokerages Abivax SA Sponsored ADR (NASDAQ: ABVX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the sixteen research firms that are currently covering the company, MarketBeat.com…
benzinga.com Accenture, Abivax and 3 Stocks to Watch Heading Into Monday With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
benzinga.com Accenture, Abivax and 3 Stocks to Watch Heading Into Monday Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
zacks.com 4 Biotech Stocks to Watch as Potential Takeover Targets Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late-stage and commercial assets.- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ABIVAX Société Anonyme (NASDAQ:ABVX) will release its first-half earnings report after the closing bell on Monday, Sept. 21.
benzinga.com Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.
benzinga.com This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more
benzinga.com Goldman Sachs Initiates Coverage On Abivax with Buy Rating, Announces Price Target of $155 Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $155.
zacks.com Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why Abivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
defenseworld.net Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of “Moderate Buy” by Brokerages Shares of Abivax SA Sponsored ADR (NASDAQ: ABVX - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen brokerages that are presently covering the stock, Marketbeat…- benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com Abivax Completes Pre-New Drug Application Interaction For Obefazimod With FDA To Treat Adults With Moderately To Severely Active Ulcerative Colitis Abivax SA (Euronext PARIS:FR0012333284 – ABVX / Nasdaq: ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural
- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
seekingalpha.com Abivax: Obefazimod Goes The Distance And So Does My Buy Rating Abivax (ABVX) maintains a Buy rating, supported by robust Phase 3 maintenance data for obefazimod in ulcerative colitis. ABVX demonstrated clinical remission rates of 50.8%–51.3% at week 44, with…
zacks.com Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross? After reaching an important support level, Abivax SA Sponsored ADR (ABVX) could be a good stock pick from a technical perspective. ABVX recently experienced a "golden cross" event, which saw its…
cnbc.com Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without backing from Big Pharma, its CEO told CNBC on Friday. The French biotech has been under…- benzinga.com 9 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Piper Sandler Maintains Overweight on Abivax, Raises Price Target to $175 Piper Sandler analyst Allison Bratzel maintains Abivax (NASDAQ:ABVX) with a Overweight and raises the price target from $165 to $175.
fool.com 3 Soaring Stocks That May Have More Upside Ahead The sky is the limit for these companies.
marketbeat.com Abivax: Wall Street Catches Up to the Data Shares of Abivax NASDAQ: ABVX were up more than 40% in the month ending July 6, after the company announced positive results from its late-stage (Phase 3) trial of its lead candidate, Obefazimod,…
globenewswire.com Abivax Announces Closing of $920 Million Public Offering Abivax Announces Closing of $920 Million Public Offering PARIS, France, July 6, 2026 –10:05 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a…
benzinga.com Truist Securities Maintains Buy on Abivax, Raises Price Target to $155 Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price target from $135 to $155.
benzinga.com Why SurgePays Shares Are Trading Higher By 59%; Here Are 20 Stocks Moving Premarket Surgepays Inc (NASDAQ: SURG) rose in pre-market trading after amending agreement with wireless network provider, shares jumped 59% to $0.66.
wsj.com Abivax Shares Continue Climbing After Biotech Firm Moves to Bolster Balance Sheet Shares rose 5% after the biotech moved to bolster its balance sheet through an upsized stock offering, signaling investor appetite in the wake of positive clinical-trial data.
globenewswire.com Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M) Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)
reuters.com Abivax nears $11 billion valuation after fundraising eases M&A pressure Abivax SA raised $800 million in an expanded share sale on Wednesday after strong investor demand, valuing the French biotechnology company at nearly $11 billion and easing pressure to pursue a…- benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
- benzinga.com Citizens Reiterates Market Outperform on Abivax, Maintains $187 Price Target Citizens analyst Jason N. Butler reiterates Abivax (NASDAQ:ABVX) with a Market Outperform and maintains $187 price target.
- benzinga.com Abivax Announces Pricing Of Underwritten Public Offering Of 6.40M ADSs At $125.00 Each Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary SharesUpsized offering increased from the previously announced $600M to $800M at $125.00…